Hypoxia-Induced Scleral HIF-2α Upregulation Contributes to Rises in MMP-2 Expression and Myopia Development in Mice.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
08 07 2022
08 07 2022
Historique:
entrez:
8
7
2022
pubmed:
9
7
2022
medline:
14
7
2022
Statut:
ppublish
Résumé
Scleral hypoxia is a key factor that induces hypoxia-inducible factor-1α (HIF-1α) upregulation, and this response contributes to myopia progression. Currently, we aim to determine if the different HIF subtypes, including HIF-1α and HIF-2α, mediate hypoxia-induced myopia development through promoting scleral MMP-2 expression and collagen degradation. Our study included: (1) time-course of scleral HIF-2α, MMP-2, and COL1α1 expression during form-deprivation myopia (FDM) development was determined in C57BL/6J mice. (2) The effect of silencing either HIF-1Α or HIF-2A on hypoxia-induced alterations in MMP-2 expression was analyzed in cultured human scleral fibroblasts (HSFs) under a hypoxic condition (i.e. 1% oxygen). (3) To knock-down either HIF-1α or HIF-2α expression in the sclera, we performed Sub-Tenon's capsule injection of an adeno-associated virus (AAV)8-packaged Cre overexpression vector (AAV8-Cre) in HIF-1αfl/fl or HIF-2αfl/fl mice. HIF-1α, HIF-2α, MMP-2, and COL1α1 expression were analyzed by Western blot or quantitative real-time PCR (qRT-PCR). In addition, the effects of scleral HIF-2α knock-down on normal refractive development and FDM development were evaluated. The time-dependent increases in scleral HIF-2α mimicked the HIF-1α expression profiles as we previously described. Hypoxia significantly promoted MMP-2 expression in HSFs, and this upregulation was solely alleviated by HIF-2A rather than HIF-1A silencing. Scleral HIF-2α knockdown significantly inhibited form-deprivation (FD)-induced MMP-2 upregulation and declines in COL1α1 accumulation and myopia development. Although scleral HIF-1α knockdown also significantly suppressed FD-induced declines in COL1α1 accumulation, it did not abrogate scleral MMP-2 upregulation. HIF-2α rather than HIF-1α induces myopia development through upregulating MMP-2 and promoting collagen degradation in the sclera.
Identifiants
pubmed: 35802383
pii: 2783450
doi: 10.1167/iovs.63.8.2
pmc: PMC9279925
doi:
Substances chimiques
Basic Helix-Loop-Helix Transcription Factors
0
endothelial PAS domain-containing protein 1
1B37H0967P
Collagen
9007-34-5
Matrix Metalloproteinase 2
EC 3.4.24.24
Mmp2 protein, mouse
EC 3.4.24.24
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2Références
Am J Pathol. 2020 Sep;190(9):1888-1908
pubmed: 32553806
EBioMedicine. 2020 Jul;57:102878
pubmed: 32652319
J Huazhong Univ Sci Technolog Med Sci. 2005;25(4):382-4, 407
pubmed: 16196282
Exp Eye Res. 2006 Feb;82(2):185-200
pubmed: 16202407
Proc Natl Acad Sci U S A. 2018 Jul 24;115(30):E7091-E7100
pubmed: 29987045
Exp Eye Res. 2013 Sep;114:128-40
pubmed: 23399866
Exp Eye Res. 2022 May;218:109018
pubmed: 35240197
Cell Mol Gastroenterol Hepatol. 2015 Sep 25;1(6):589-597
pubmed: 28210703
Cell Tissue Res. 2010 Jan;339(1):19-29
pubmed: 19662436
Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):3
pubmed: 33909035
Clin Exp Optom. 2015 Nov;98(6):507-17
pubmed: 26769177
Ophthalmic Physiol Opt. 2020 Sep;40(5):567-576
pubmed: 32839973
J Mol Cell Cardiol. 2018 Aug;121:36-50
pubmed: 29913136
Exp Eye Res. 1996 Oct;63(4):369-81
pubmed: 8944544
Circ Res. 2002 Apr 19;90(7):784-91
pubmed: 11964371
Am J Pathol. 2018 Aug;188(8):1754-1767
pubmed: 29803830
J Med Genet. 2022 Jan;59(1):88-100
pubmed: 33318135
Neuron. 2004 Aug 19;43(4):447-68
pubmed: 15312645
Oncol Lett. 2016 Jun;11(6):3743-3748
pubmed: 27313686
IUBMB Life. 2016 Sep;68(9):756-63
pubmed: 27521280
FASEB J. 2001 Nov;15(13):2445-53
pubmed: 11689469
Am J Physiol Cell Physiol. 2016 Feb 15;310(4):C260-9
pubmed: 26561641
Lancet. 2012 May 5;379(9827):1739-48
pubmed: 22559900
FASEB J. 2003 Feb;17(2):271-3
pubmed: 12490539
Invest Ophthalmol Vis Sci. 2016 Aug 01;57(10):4412-4419
pubmed: 27750284
J Mol Cell Cardiol. 2009 Sep;47(3):391-9
pubmed: 19523958
Cell. 2012 Feb 3;148(3):399-408
pubmed: 22304911
Ophthalmology. 2016 May;123(5):1036-42
pubmed: 26875007
Development. 2012 Dec 1;139(23):4473-83
pubmed: 23095889
Cell Rep. 2014 Mar 27;6(6):1110-1121
pubmed: 24613356
Retina. 2017 Dec;37(12):2347-2351
pubmed: 28590964
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5208-14
pubmed: 18689702
Exp Eye Res. 2020 Apr;193:107956
pubmed: 32032629
Acta Med Okayama. 2012;66(5):399-407
pubmed: 23093058
Oncogene. 2006 Apr 13;25(16):2379-92
pubmed: 16369494
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Nature. 2019 Jan;565(7740):511-515
pubmed: 30651640
Curr Eye Res. 2006 Jul-Aug;31(7-8):587-97
pubmed: 16877267
Optom Vis Sci. 2004 Feb;81(2):99-110
pubmed: 15127929
Arthritis Rheum. 2009 Oct;60(10):3038-48
pubmed: 19790048